Phase behavior of rifampicin in cholesterol-based liquid crystals and polyethylene glycol.

Eur J Pharm Sci

Drug Delivery System Excellence Center, Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat Yai, Thailand.

Published: December 2012

The phase behavior of rifampicin in cholesteryl-based carbonate esters (CCEs), cholesterol and polyethylene glycol4000 (PEG4000) was determined to evaluate their potential in the formulation of dry powder inhalation dosage forms. To guide the identification of the most suitable liquid crystalline system for the solubilization of rifampicin, the dielectric constants were evaluated. Thereafter, the phase behavior of various mixtures were characterized by polarized light microscope (PLM), transmission electron microscopy (TEM), X-ray diffraction (XRD) and differential scanning calorimetry (DSC). Among the mixed-carrier systems, the cholesteryl cetyl carbonate (CCC) and PEG4000 system at 1:1 mole ratios yielded a homogeneous mixture with relatively high rifampicin content. This result was consistent with the prediction based on the dielectric constants. The phase diagram contained a eutectic point at CCC:PEG4000 (1:1) and 50 °C. Finally, the rifampicin drug was successfully incorporated into CCC and PEG system at a 1:6:6 mole ratio. Such a system would be amenable for oral inhalation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejps.2012.09.011DOI Listing

Publication Analysis

Top Keywords

phase behavior
12
behavior rifampicin
8
dielectric constants
8
rifampicin
5
phase
4
rifampicin cholesterol-based
4
cholesterol-based liquid
4
liquid crystals
4
crystals polyethylene
4
polyethylene glycol
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!